Skip to main content
SpringerLink
Log in

Diagnostic use of the sentinel node in colon cancer

  • Original Contributions
  • Published:
Diseases of the Colon & Rectum

Abstract

PURPOSE: The aim of this study was to compare the lymphatic drainage of colon cancer with the anatomic distribution of histologic and submicroscopic lymph node metastases. METHODS: Patients attending for colectomy were eligible to enter the study. At the commencement of surgery, 40 MBq of 99mTc colloidal antimony sulfide in 2 ml of Patent Blue dye was injected subserosally around the tumor. Resection was completed in a standard fashion. After resection, specimens were imaged with a gamma camera to determine the site of sentinel lymph nodes, and then dissected, recording the position of the lymph nodes on an anatomic diagram. Recovered lymph nodes were bisected, one-half for routine histology and one-half for assessment by keratin 20 (K20) reverse transcription polymerase chain reaction. The kappa measure of agreement was used to assess concordance between sentinel nodes and histologic and submicroscopic metastases. RESULTS: Four hundred fifty-six lymph nodes were dissected from 26 tumors and evaluated using lymphoscintigraphy and lymph node mapping. Sentinel nodes were evident in 23 tumors (88 percent). The sensitivity of sentinel nodes involvement as a predictor of metastatic disease was 55 percent (95 percent confidence interval, 23–83), with a false negative (nondiagnostic) rate of 45 percent. Sentinel nodes involved the apical group in four tumors, and represented anatomic “skip” lesions in four tumors. CONCLUSIONS: Direct lymphatic drainage to the apical group does occur in colon cancer; however, sentinel node mapping of colon cancer by this technique is of little clinical value because of the poor concordance between lymph node metastases and sentinel nodes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Fielding LP, Phillips RK, Fry JS, Hittinger R. Prediction of outcome after curative resection for large bowel cancer. Lancet 1986;2:904–7.

    Google Scholar 

  2. Wiggers T, Arends JW, Schutte B, Volovics L, Bosman FT. A multivariate analysis of pathologic prognostic indicators in large bowel cancer. Cancer 1988;61:386–95.

    Google Scholar 

  3. Cohen AM, Tremiterra S, Candela F, Thaler HT, Sigurdson ER. Prognosis of node-positive colon cancer. Cancer 1991;67:1859–61.

    Google Scholar 

  4. Hyder JW, Talbott TM, Maycroft TC. A critical review of chemical lymph node clearance and staging of colon and rectal cancer at Ferguson Hospital, 1977 to 1982. Dis Colon Rectum 1990;33:923–5.

    Google Scholar 

  5. Wolmark N, Fisher B, Wieand HS. The prognostic value of the modifications of the Dukes' C class of colorectal cancer. An analysis of the NSABP clinical trials. Ann Surg 1986;203:115–22.

    Google Scholar 

  6. Newland RC, Dent OF, Lyttle MN, Chapuis PH, Bokey EL. Pathologic determinants of survival associated with colorectal cancer with lymph node metastases. A multivariate analysis of 579 patients. Cancer 1994;73:2076–82.

    Google Scholar 

  7. Malassagne B, Valleur P, Serra J,et al. Relationship of apical lymph node involvement to survival in resected colon carcinoma. Dis Colon Rectum 1993;36:645–53.

    Google Scholar 

  8. Phillips RK, Hittinger R, Blesovsky L, Fry JS, Fielding LP. Large bowel cancer: surgical pathology and its relationship to survival. Br J Surg 1984;71:604–10.

    Google Scholar 

  9. Shida H, Ban K, Matsumoto M,et al. Prognostic significance of location of lymph node metastases in colorectal cancer. Dis Colon Rectum 1992;35:1046–50.

    Google Scholar 

  10. Tang R, Wang JY, Chen JS,et al. Survival impact of lymph node metastasis in TNM stage III carcinoma of the colon and rectum. J Am Coll Surg 1995;180:705–12.

    Google Scholar 

  11. Coates AS, Ingvar CI, Petersen-Schaefer K,et al. Elective lymph node dissection in patients with primary melanoma of the trunk and limbs treated at the Sydney Melanoma unit from 1960 to 1991. J Am Coll Surg 1995;180:402–9.

    Google Scholar 

  12. Balch CM, Soong SJ, Bartolucci AA,et al. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg 1996;224:255–63.

    Google Scholar 

  13. Greco M, Agresti R, Raselli R, Giovanazzi R, Veronesi U. Axillary dissection can be avoided in selected breast cancer patients: analysis of 401 cases. Anticancer Res 1996;16:3913–7.

    Google Scholar 

  14. Pezim ME, Nicholls RJ. Survival after high or low ligation of the inferior mesenteric artery during curative surgery for rectal cancer. Ann Surg 1984;200:729–33.

    Google Scholar 

  15. Surtees P, Ritchie JK, Phillips RK. High versus low ligation of the inferior mesenteric artery in rectal cancer. Br J Surg 1990;77:618–21.

    Google Scholar 

  16. Corder AP, Karanjia ND, Williams JD, Heald RJ. Flush aortic tie versus selective preservation of the ascending left colic artery in low anterior resection for rectal carcinoma. Br J Surg 1992;79:680–2.

    Google Scholar 

  17. Cady B. Lymph node metastases. Indicators, but not governors of survival. Arch Surg 1984;119:1067–72.

    Google Scholar 

  18. NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 1990;264:1444–50.

    Google Scholar 

  19. Gabriel W, Dukes C, Bussey H. Lymphatic spread in cancer of the rectum. Br J Surg 1935;23:395–413.

    Google Scholar 

  20. McMinn RM. Last's anatomy, regional and applied. 8th ed. Melbourne: Churchill Livingstone, 1994:330–2.

    Google Scholar 

  21. Herrera-Ornelas L, Justiniano J, Castillo N, Petrelli NJ, Stulc JP, Mittelman A. Metastases in small lymph nodes from colon cancer. Arch Surg 1987;122:1253–6.

    Google Scholar 

  22. Merrie AE, Phillips LV, Yun K, McCall JL. Skip lesions in colon cancer: assessment by lymph node mapping [abstract]. Eur J Nucl Med 1999;26:S73.

    Google Scholar 

  23. Uren RF, Howman-Giles RB, Thompson JF, Shaw HM, McCarthy WH. Lymphatic drainage from peri-umbilical skin to internal mammary nodes. Clin Nucl Med 1995;20:254–5.

    Google Scholar 

  24. Uren RF, Howman-Giles R, Thompson JF,et al. Lymphatic drainage to triangular intermuscular space lymph nodes in melanoma on the back. J Nucl Med 1996;37:964–6.

    Google Scholar 

  25. Uren RF, Howman-Giles R, Thompson JF, Quinn MJ. Direct lymphatic drainage from the skin of the forearm to a supraclavicular node. Clin Nucl Med 1996;21:387–9.

    Google Scholar 

  26. Thompson JF, Saw RP, Colman MH, Howman-Giles RB, Uren RF. Contralateral groin node metastasis from lower limb melanoma [letter]. Eur J Cancer 1997;33:976–7.

    Google Scholar 

  27. Hunt JA, Thompson JF, Uren RF, Howman-Giles R, Harman CR. Epitrochlear lymph nodes as a site of melanoma metastasis. Ann Surg Oncol 1998;5:248–52.

    Google Scholar 

  28. Uren RF, Howman-Giles R, Thompson JF. Lymphatic drainage from the skin of the back to retroperitoneal and paravertebral lymph nodes in melanoma patients. Ann Surg Oncol 1998;5:384–7.

    Google Scholar 

  29. Borgstein PJ. Consequences of lymphatic tumour spread in melanoma and breast cancer. Amsterdam: Vrije Universiteit te Amsterdam 1999:20–2.

  30. Morton DL, Wen DR, Wong JH,et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392–9.

    Google Scholar 

  31. Reintgen D, Cruse CW, Wells K,et al. The orderly progression of melanoma nodal metastases. Ann Surg 1994;220:759–67.

    Google Scholar 

  32. Veronesi U, Paganelli G, Galimberti V,et al. Sentinelnode biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997;349:1864–7.

    Google Scholar 

  33. Turner RR, Ollila DW, Krasne DL, Giuliano AE. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg 1997;226:271–6.

    Google Scholar 

  34. Krag D, Weaver D, Ashikaga T,et al. The sentinel node in breast cancer—a multicenter validation study. N Engl J Med 1998;339:941–6.

    Google Scholar 

  35. Bass S, Cox C, McCann C, Dupont E, Berman C, Reintgen D. The effects of post injection massage on the sensitivity of lymphatic mapping in breast cancer [abstract]. Eur J Nucl Med 1999;26:S66.

    Google Scholar 

  36. Gunn J, McCall JL, Yun K, Wright PA. Detection of micrometastases in colorectal cancer patients by K19 and K20 reverse-transcription polymerase chain reaction. Lab Invest 1996;75:611–6.

    Google Scholar 

  37. Uren RF, Howman-Giles RB, Shaw HM, Thompson JF, McCarthy WH. Lymphoscintigraphy in high risk melanoma of the trunk: predicting drainage node groups, defining lymphatic channels, and locating the sentinel node. J Nucl Med 1993;34:1435–40.

    Google Scholar 

  38. Uren RF, Howman-Giles RB, Thompson JF,et al. Mammary lymphoscintigraphy in breast cancer. J Nucl Med 1995;36:1775–80.

    Google Scholar 

  39. O'Brien CJ, Uren RF, Thompson JF,et al. Prediction of potential metastatic sites in cutaneous head and neck melanoma using lymphoscintigraphy. Am J Surg 1995;170:461–6.

    Google Scholar 

  40. Dukes C. The classification of cancer of the rectum. J Pathol Bacteriol 1932;35:323–32.

    Google Scholar 

  41. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas 1960;20:37–46.

    Google Scholar 

  42. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159–74.

    Google Scholar 

  43. Pijpers R, Borgstein PJ, Meijer S, Hoekstra OS, van Hattum LH, Teule GJ. Sentinel node biopsy in melanoma patients: dynamic lymphoscintigraphy followed by intraoperative gamma probe and vital dye guidance. World J Surg 1997;21:788–92.

    Google Scholar 

  44. Bostick P, Essner R, Sarantou T,et al. Intraoperative lymphatic mapping for early-stage melanoma of the head and neck. Am J Surg 1997;174:536–9.

    Google Scholar 

  45. McIntosh SA, Purushotham AD. Lymphatic mapping and sentinel node biopsy in breast cancer. Br J Surg 1998;85:1347–56.

    Google Scholar 

  46. Joosten JJ, Strobbe LJ, Wauters CA, Pruszczynski M, Wobbes T, Ruers TJ. Intraoperative lymphatic mapping and the sentinel node concept in colorectal carcinoma. Br J Surg 1999;86:482–6.

    Google Scholar 

  47. Albertini JJ, Cruse CW, Rapaport D,et al. Intraoperative radio-lympho-scintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg 1996;223:217–24.

    Google Scholar 

  48. Leong SP, Steinmetz I, Habib FA,et al. Optimal selective sentinel lymph node dissection in primary malignant melanoma. Arch Surg 1997;132:666–72.

    Google Scholar 

  49. Shivers SC, Wang X, Li W,et al. Molecular staging of malignant melanoma: correlation with clinical outcome. JAMA 1998;280:1410–5.

    Google Scholar 

  50. van Diest PJ, Peterse HL, Borgstein PJ, Hoekstra O, Meijer CJ. Pathological investigation of sentinel lymph nodes. Eur J Nucl Med 1999;26:S43–9.

    Google Scholar 

  51. Kollias J, Gill PG, Chatterton B, Raymond W, Collins P. Sentinel node biopsy in breast cancer: recommendations for surgeons, pathologists, nuclear physicians and radiologists in Australia and New Zealand. Aust N Z J Surg 2000;70:132–6.

    Google Scholar 

  52. Yun K, Merrie AE, Gunn J, Phillips LV, McCall JL. Keratin 20 is a specific marker of submicroscopic lymph node metastases in colorectal cancer: validation by K-RAS mutations. J Pathol 2000;191:121–6.

    Google Scholar 

  53. Merrie AE, Phillips LV, Yun K, McCall JL. Validation of Keratin 20 as a marker of colorectal cancer lymph node metastases by analysis of K-RAS mutations [abstract]. Aust N Z J Surg 1999;69:A24.

  54. Makar A, Melis K, Van den Weyngaert D, Van Leuven L, Declercq S, Joosens E. Identification ratio of the sentinel node in patients with primary breast cancer. A pathological correlation [abstract]. Eur J Nucl Med 1999;26:S55.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. From the Department of Surgery, Dunedin School of Medicine, University of Otago, Dunedin

    Arend E. H. Merrie M.B.Ch.B., Ph.D., André M. van Rij M.D. (F.R.A.C.S.), Lynne V. Phillips (N.Z.C.S.) & Jeremy I. Rossaak (M.B.Ch.B.)

  2. the Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin

    Kankatsu Yun M.D., Ph.D.

  3. Department of Surgery, Faculty of Health Science, University of Auckland, Auckland, New Zealand

    John L. McCall M.D. (F.R.A.C.S.)

Authors
  1. Arend E. H. Merrie M.B.Ch.B., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. André M. van Rij M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lynne V. Phillips
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jeremy I. Rossaak
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kankatsu Yun M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. John L. McCall M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Supported by a grant from the Dunedin School of Medicine and by the Royal Australasian College of Surgeons Richard Stewart Scholarship (AEH Merrie) and the New Zealand Gastroenterological Society-Glaxo/Wellcome Research Fellowship (AEH Merrie).

About this article

Cite this article

Merrie, A.E.H., van Rij, A.M., Phillips, L.V. et al. Diagnostic use of the sentinel node in colon cancer. Dis Colon Rectum 44, 410–417 (2001). https://doi.org/10.1007/BF02234742

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02234742

Key words

Search

Navigation